ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
scaffold_1_1546 # 1577155 # 1577382 # 1 # ID=1_1546;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.627	scaffold_1_1546 	1577155	1577382	+	Strict	550	21.1718	OXA-153	100.0	3001458	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGTTTCTTCATCCACGCGGAGAGCAGGCGGCGGTTGATGGCGTTGTCGTCTACGATGAGGGCTTGGGTGATGTGAAGGCGCTGTTCATCCTGGATTGGGGCTGGGGGCTGGACGTCTGGCGCCGCGGGGTCTTTGGACTTGGACCTTCGCAGGGCGAGGGTGGGAGATGGGTAAAGCCCGATTCTGGGTCCGAATTCGCGGGTGGAGTCTTGCGGGGCGCTCCATGA	MFLHPRGEQAAVDGVVVYDEGLGDVKALFILDWGWGLDVWRRGVFGLGPSQGEGGRWVKPDSGSEFAGGVLRGAP	MKKIISRWRRGVFGLRVALAVVSPMVFAVPAHATEAAGGAAGTKAAAVHMKERADWGKFFDAEGVKGTIVVLDGRTQTYQAFDTARAERRMSPASTYKIFNSLLALESGALDNEREIIPWDGKPRRGKYWNAAMDLRTAFRVSCLPCYQVVSHKIARQFAQSKLNEAGYGNHTIGRAADAYWVDDSLQISAREQVDFLQRLARGTLPFSARSQDIVRQISIVEANPDYVLHGKTGWFVDKKPDIGWWVGWIERDGNITSVALNIDLKDDADAPKRARIVRAVLSSLQLI	25.95	gnl|BL_ORD_ID|2610|hsp_num:0	3417	True	loose hit with at least 95 percent identity pushed strict
scaffold_2_1058 # 1134073 # 1134264 # 1 # ID=2_1058;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.542	scaffold_2_1058 	1134073	1134264	+	Strict	750	20.7866	mdtH	100.0	3001216	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGTGTGGCATCTTCGGCGGTGCGATCGCCCATCTCAATGTCGTAGTAGTGAGCATTGAGCATGTTGAGCGTGCTGACAGACGTATGCTTATTGGCTGTTGCCTTATTGGCGAGTGCGGGATAGCGGATGACATCGATGTCTTTCTGGACTTTGACGCCGCCGTGGGCATCGACCGAGACGGAAGTGTTTGA	MCGIFGGAIAHLNVVVVSIEHVERADRRMLIGCCLIGECGIADDIDVFLDFDAAVGIDRDGSV	MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQGLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPRSALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAFNAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAGAPSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQLFTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLGKSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA	15.67	gnl|BL_ORD_ID|349|hsp_num:0	375	True	loose hit with at least 95 percent identity pushed strict
scaffold_3_1037 # 1029550 # 1029807 # 1 # ID=3_1037;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.527	scaffold_3_1037 	1029550	1029807	+	Strict	2300	22.3274	evgS	100.0	3000833	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTTCGCGTGGCTAACGACTGCAGGTGATGAGAAGGGCACAGACTGGGCAGGCCAGGTCAGCGAGAAGGACGTCGACGACCATCCGACAAATCGAGCGGGAAGGCCCAAGGACATTGCTGATGCGGCTCTATATCTCATCGATGCAGGCTTCATTACAGGTATGCCCCCTTGCTTTCAACTTGCGTACATCAAGCTAATCGGAAATCAAGGCCAAGACATTACGGTGGACGGAGGAGCTCTGAGAAAGAAACATTGA	MFAWLTTAGDEKGTDWAGQVSEKDVDDHPTNRAGRPKDIADAALYLIDAGFITGMPPCFQLAYIKLIGNQGQDITVDGGALRKKH	MKFLPYIFLLCCGLWSTISFADEDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVIAVHKSQTATLLHTDSQQRVRGINADYLNLLKRALNIKLTLREYADHQKAMDALAEGEVDIVLSHLVTSPPLNNDIAATKPLIITFPALVTTLHDSMRPLTSPKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGHNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQYNFFLTRKESVILNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQHPNLKVLENPYSPPYSMTDENGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLSPGGWDIIPGAIYSEDRENNVLFAEAFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHSQLKEMYPEVEWIQVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVPNASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVTTLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIYTQVFEIDNGIEKRCINHWHTLCNLPASDNAVYICGWQDITETRDLINALEVEKNKAIKATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQLQPQWVDIPTLVQNTCHSFGAIAASKSIALSCSSTFPEHYLVKIDPQAFKQVLSNLLSNALKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGSGLGLMICKELIKNMQGDLSLESHPGIGTTFTITIPVEISQQVATVEAKAEQPITLPEKLSILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKVSMQHYDLLITDVNMPNMDGFELTRKLREQNSSLPIWGLTANAQANEREKGLSCGMNLCLFKPLTLDVLKTHLSQLHQVAHIAPQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFQALEAGDNRTFHQCIHRIHGAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEIAVFCQKND	7.10	gnl|BL_ORD_ID|1243|hsp_num:0	1318	True	loose hit with at least 95 percent identity pushed strict
scaffold_8_371 # 369533 # 369847 # 1 # ID=8_371;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.552	scaffold_8_371 	369533	369847	+	Strict	1450	22.7126	BahA	100.0	3003984	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic inactivation	Bah amidohydrolase	ATGCCCCGCGATGAGCAAGAGACGTACATCCAGCGTCTCGCCAAGCTCGGTTACTGCTGGCAATTCATCACGCTTGCTGGTCTGCACCAGAGTGCGCTCATGGCGGACACCTTCTCGAAAGCGTATGCCAAGCAGGGTATGCGTGCGTACGGCGAGATCATCCAAGAGCCGGAGGCGGAGAACAAGGTCGATGTTCTTACGCATCAGAAGTGGAGTGGAGCGAATTATGTGGACAATATGCTCAAGATGGTTAGTGGCGGTGTGAGCTCGACGGCGGCGATGGGTAAGGGTGTTACGGAGGATCAGTTCAAGTAA	MPRDEQETYIQRLAKLGYCWQFITLAGLHQSALMADTFSKAYAKQGMRAYGEIIQEPEAENKVDVLTHQKWSGANYVDNMLKMVSGGVSSTAAMGKGVTEDQFK	MEIHKEKEKEKGVTFFRRIMANRKRRGPLSPGWKGASLGLGATGFILILIQANYLLTGHGVGKFIVGTFLFLFAAALISGLASMLLHGVKKLPSRYIWMLLYSLIMFLFCFIVQPGVSAVFIVSLAIVLSLFGALAYKFAAGSYKQVSKTRKIGAMACLSLITIAIGAGSFWLIRAGDDAAPDITLKQLKTSTRYEDSTMNNPAEQGTYPVQSLLYGSPDNYRTEFNQSGSLTTQTVDASRFVEKWSSLRTKSLGFGPEAMPLNGRVWYPEGEGTFPLVLIVHGNHLMNDYSDPGYEYLGRLLASKGYIFVSVDENFLNFSPYEDLFLISPLLSENPARGLLLLEHLQTWKDWNSDPDNPFYQKVDMERIALIGHSRGGEAVAIAAAYNKLGRHPDHGDIKFDYNFSIRSLISIAGTDGQYKPQGKPLPLQDVNYLSLHGAHDMDVNSLDGAKQYHRIRYTKGTNYMKSLVYIYGANHGQFNGGWGRGDGAGLGNQLFNLRQIMPRDEQETIAKVFISSFLDATLKDQRQYREVFKDLGYAKEWIPDNLYVGNYYDSQTTLIADFHEDIDLQSTTLPGGSLRGENLQQWKEEKVKTKWGEADYSAVRLGWNSNGSSEPASYTVTLPDNGVETGRDSSIVFSLADARKTEESGDPKELINFTITVEDRKGHQASLPLSHISKLPPVIEGKLLKWPFSNAGNTSEPVFQSYDFQLDDYYKMNPDFNPQQLSKIRIEFNLTKRGSILLRDVGIRS	13.83	gnl|BL_ORD_ID|2290|hsp_num:0	2521	True	loose hit with at least 95 percent identity pushed strict
scaffold_11_253 # 283798 # 283929 # -1 # ID=11_253;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=3-4bp;gc_cont=0.447	scaffold_11_253 	283798	283929	-	Strict	500	20.0162	vanYG1	100.0	3002959	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanY; glycopeptide resistance gene cluster	ATGCTCCGCGAGCACATGTGTATAAACATATCGAGTGGACATGAACATGTCGCAGTTCAGAATCAAGCATCAAGTTTTCTTTGGTACTGTAGCTGGGAGTATGCTGGTGATGTGCTTGAGAATGTGGGGTGA	MLREHMCINISSGHEHVAVQNQASSFLWYCSWEYAGDVLENVG	MNHMNMKHRRRKRRRNQSFLFTGILLLVVVSASSFLWYGFGNAAKKDSVIEEMPFTITQDGMQAKEEIKKTVLETSYGGKQQVAEENHGNTQNAGTDEAWNLMLVNRDNAIPDNYEVNLVEVEGGERVDERIYEPLMEMLNAAREENWGELPMVVSGYRTQEKQQSLYDEKIAKFKKEGYSDSEAVRQAEQWVAVPGHSEHQLGFAVDINGATYDVYLWLQENSYKYGFIFRYPGSKTDITGTAEEVWHYRYVGVEAATEMYENGLCLEEYLEKKQSEN	15.41	gnl|BL_ORD_ID|277|hsp_num:0	298	True	loose hit with at least 95 percent identity pushed strict
scaffold_12_296 # 280799 # 281032 # 1 # ID=12_296;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.560	scaffold_12_296 	280799	281032	+	Strict	900	25.409	adeH	100.0	3000779	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGAGCGGCCACTGTTTGACGGAGGGCAAAGGAAGCGTAGCTGTCGGCTTCGCAGGAATGGCTTTGCTGTCGACGATGTTCCGGCTTCGATCAGCTTCTTGGAGCAAATTGGCTTTGATGTAGGCGCAGAGATGGCGCATGTCGGCTTCGTTGATGCTGTGGAGCGCAGCGACAGGAACTGCCTCAGCACGACGCATGTTCTCGAAGGCTTTTTCAAGCGGCTTTGTCGGTAG	MERPLFDGGQRKRSCRLRRNGFAVDDVPASISFLEQIGFDVGAEMAHVGFVDAVERSDRNCLSTTHVLEGFFKRLCR	MVITSKQNWLLSSLMGSLLLAGCSLAPEYQPAKVIVPVKFKESDPKLEDNNWKIAQPADQQTRGEWWRIYNDAQLNELEQQAIAGNQNLKAVAANIQASRALRSAAQAERLPSIDAGFGPTRQKPSPASLGLDDNAHTSAQTLWRAQANVSYELDLFGRVASSVNAATADLQQQEALYQSALLALQADVAQGYFLIRQLDTEQAIYNRTIKLLGETRDLMQLRFKNGLVSELDVSRAQTELATAQTTALNIARNRASAEHALAVLLGKPPADFNLAVQPLTANSIRLPAGLPSTLLERRPDIAAAERAMAADNARIGIARAAFFPKLSLTGALGYESSSLSELGKWSSRTFLLGPVAGTILSLPLFDGGQRKAGVAQARAAYEESVANYRQTVLNAFREVENGLSDQRILDQQIQAQNQALSSSRHANQLSHLRYREGAISYLDVIDSDRTILQQEQLAAQLKGSQIIASINLIRALGGGWSS	15.94	gnl|BL_ORD_ID|505|hsp_num:0	542	True	loose hit with at least 95 percent identity pushed strict
scaffold_15_811 # 780146 # 780820 # 1 # ID=15_811;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.612	scaffold_15_811 	780146	780820	+	Strict	300	23.8682	AAC(3)-VIIa	100.0	3002541	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	GTGCTTGGCCGGCTCGCTGTGGGCAGGGGACGCATACTGGAAAGGCGAAGGCTTGAGCATGGGGTTGTGCATGATGCTGCCGTCTGGGGACGCGTCGGGGGTAGGAGGACGAACACCAGCAGAGCCGTTGCGCCAGATCTCCTCGAGTTGCGCTGGCGAGACATCAGCACCGTAGTCGGCGGCGACCGTGGCCCAGAATTGGTTGCGGCGGGCCTCGTAAATGGAGCGGAGGCGGTCAGTGTCGACAACCTTGGGCTGATGAGCGACCTCGGTGTTAATGCGCAGGCCGTTGAAGGGTTCGGGAGATCCCTGAGGGGTGAGGGTGCGCGGCTTGGGCAGGAGAATCTTGTGCTGAGCACGTCCAGGGGAAGCAGTGACGGACCCGGCCCTAATGTGCGGGCTACCGTTGTAGCTCATCGGGGAGCTGTGACGGGAAGACTGCGAGTACGCGTCGTGGTCGATAGCCATGGCATAGGCCGGAGAGGTACCGTTGGAGCTGCAGGAGGTGGCGGAAGAAACAGACGAGGTGCGCTTGCGGCGGTGGCTACCGTGGGAAAGCTGGTGGAAGTGCAGGCGGCATGCAAGCTCAGTCTTCTTGAGATGTGCAGCAATGTGCTTGTAAGGCATCTTCTGCATGCGGGTCTGAAGCAGATAGTTCTCCTAGAGACATGTTAA	MLGRLAVGRGRILERRRLEHGVVHDAAVWGRVGGRRTNTSRAVAPDLLELRWRDISTVVGGDRGPELVAAGLVNGAEAVSVDNLGLMSDLGVNAQAVEGFGRSLRGEGARLGQENLVLSTSRGSSDGPGPNVRATVVAHRGAVTGRLRVRVVVDSHGIGRRGTVGAAGGGGRNRRGALAAVATVGKLVEVQAACKLSLLEMCSNVLVRHLLHAGLKQIVLLETC	MDELALLKRSDGPVTRTRLARDLTALGLGDGDTVMFHTRMSAVGYVAGGPETVIGALRDVVGERGTLMVTCGWNDAPPYDFTDWPQTWQDARRAEHPAYDPVLSEADHNNGRLPEALRRRPGAVRSRHPDASFAALGAAATALTADHPWDDPHGPDSPLARLVAMGGRVLLLGAPLEALTLLHHAEALADAPGKRFVDYEQPILVDGERVWRRFHDIDSEDGAFDYSALVPEGTEAFEIIGRDMRAAGIGRRGTVGAADSHLFEARDVVDFGVAWMEEKLGRERGPGG	77.78	gnl|BL_ORD_ID|613|hsp_num:0	653	True	loose hit with at least 95 percent identity pushed strict
scaffold_19_367 # 366407 # 366577 # 1 # ID=19_367;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.550	scaffold_19_367 	366407	366577	+	Strict	760	21.1718	macA	100.0	3000533	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGCGCGTTGGGGTGGCTGGCACGCAGGGAAGTTCCGCATTGTTGCAAGCGCCCACCAATTCAGCCCCGCACCCTTCATGCCACGGCAGCATCGAAATGATTGCGACGAACACTCCAGGGTTTTGAAGCTCGAAGAGCTCGAAGAGGAATCACAGCATATCTCATCATAA	MARWGGWHAGKFRIVASAHQFSPAPFMPRQHRNDCDEHSRVLKLEELEEESQHISS	MAKMMKWSAVAAVAAAAVWGGWHYLKPEPQAAYITETVRRGGISRTVSATGEISPSNLVSVGAQASGQIKKLYVKLGQQVKKGDLIAEINSTTQTNTLNMEKSKLETYQAKLVSAQIALGSAEKKYKRQTALWKDDATSKEDLESAQDALAAAKANVAELKALIRQSKISINTAESDLGYTRITATMDGTVVAIPVEEGQTVNAAQSTPTIVQLANLDMMLNKMQIAEGDITKVKAGQDISFTILSEPDTPIKAKLDSVDPGLTTMSSGGYNSSTDTASNAVYYYARSFVPNPDGKLATGMTTQNTVEIDGVKNVLLIPSLTVKNRGGKAFVRVLGADGKAAEREIRTGMRDSMNTEVKSGLKEGDKVVISEITAAEQQESGERALGGPPRR	14.29	gnl|BL_ORD_ID|1584|hsp_num:0	1680	True	loose hit with at least 95 percent identity pushed strict
scaffold_21_460 # 425996 # 426220 # -1 # ID=21_460;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.511	scaffold_21_460 	425996	426220	-	Strict	500	21.9422	apmA	100.0	3003918	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	amp acetyltransferase	ATGCAAACTTACAGCAGCGGGAGTCAAGTAGCGTCGTGCAAACGTTTCATAGCTGTTCCTCGCAATTTCCTCCGCCTCGTCATCGTGAACACGGTAGTATTCCATCGCGTCCTCCAGATTGCCAAAGTTCTTCGAGGCTTCGATGTAGTTGATATCTGGGCCAGAAAGGCGCAGGAGATGGGTGTGGAACTCCTGCCATTCGAGAGGATGTGTGATGAGTGCTGA	MQTYSSGSQVASCKRFIAVPRNFLRLVIVNTVVFHRVLQIAKVLRGFDVVDIWARKAQEMGVELLPFERMCDEC	MKTRLEQVLERYLNGREVAVWGVPTRRLLRALKPFKFHTADRVDPQYHYVVAVTDDDLTDFLSDEQSKSFQYANDYLTFDDEGGELPFERMCFNVPVGRQTYFGDGVVGACENGYIKSIGQFTSINGTAEIHANHQLNMTFVSDDIQNFFNEESMAVFQEKLRKDPKHPYAYSKEPMTIGSDVYIGAHAFINASTVTSIGDGAIIGSGAVVLENVPPFAVVVGVPARIKRYRFSKEMIETLLRVKWWDWSIEEINENVDALISPELFMKKYGSL	27.01	gnl|BL_ORD_ID|2220|hsp_num:0	2395	True	loose hit with at least 95 percent identity pushed strict
scaffold_25_461 # 433129 # 433320 # -1 # ID=25_461;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.542	scaffold_25_461 	433129	433320	-	Strict	350	21.1718	vanZF	100.0	3002963	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanZ; glycopeptide resistance gene cluster	ATGTCTTCGACGCCACAATCGCTTGAGGCCGCAGACTTGAAGGAGATGGACGCTACGAAGCAAATCGAGGTCTCTGGGGACCTCTCGTGGACACCCGAGGAAGAGGCCAAGCTCGTGAAGAAGATTGATCTTTTCCTGCTGCCGACGATATGGCTCATGTACCTGCTGTCGTACATGGACCGCACAAAGTAG	MSSTPQSLEAADLKEMDATKQIEVSGDLSWTPEEEAKLVKKIDLFLLPTIWLMYLLSYMDRTK	MLTPLTVLYTYFCTIIFCIVFQIGFFFKALKNISIRHFLWVYVFLFYLALVYMMTGIGNVWVVGRYETLIRVSEINLLPFSSEGVTTYILNIILFMPLGFLLPTIWPQFRTIKNTACTGFFFSLAIELTQLLNHRITDIDDLLMNTLGAIIGYLLYRAFKMIYTRDEKKLDNKSSLVIKYEAIFYIVCSFIGMILLYYPFLLRKII	30.58	gnl|BL_ORD_ID|1575|hsp_num:0	1669	True	loose hit with at least 95 percent identity pushed strict
scaffold_28_330 # 309208 # 309903 # 1 # ID=28_330;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.540	scaffold_28_330	309208	309903	+	Strict	32	34.6538	Trimethoprim-resistant dihydrofolate reductase DfrA42	25.48	3005334	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGTCCGAATCTTCTCAAGCAACAGCACAAAACCAATCGAGCACACCCGCGGCAAGCGACGCGTCCACCATGCCCAAATCCCCAAGCCTCACCCTCATACTCGCCGCCACACCCTCGTTAGGCATAGGCAAAGGCGGCACACTACCATGGCCACAACTAAAGAAGGAAATGGGCTACTTTGCGCGCGTCACGAAGCGCGTCTCCTCTCCCCAATCCACGGGCACAAGAAAAGTCAACGCAGTACTCATGGGCCGCAAGACGTGGGATAGCATACCGCCGAAATTCCGGCCGCTCAAAGATCGATTGAACATTGTGATTACGCGCAAAGCCGACGAGTTTGAGAAGACGCTGGACAAGAAGAGTGATGTCGAGGGGCCGATGGTAGCGTCGGGCATTGTAGATGCGTTGGCGCAATTGGAAGGGAAGGCGGAGGAGGTTGATCGCGTGTATGTCATTGGTGGCGCGAGTGTATATCAGACTGCGCTGGAACTGCCGCAGACGAGATATGTGTTGTTGACGAAGATACGGAAGGAGTTTGAGTGTGATACATTCTTTTCGGTGGATTTGGAGGAGAGTGCGGTGTGGCGGAGGGCTGGGAGGGAGGAGTTGCAGGAGTTTACGGGTGAGGAGGTGAAGGAGAAGGTGATCGAGGAACATGGTGTGGAGTTTGAGTTTTGTTTGTATGAAAGAGTGTAG	MSESSQATAQNQSSTPAASDASTMPKSPSLTLILAATPSLGIGKGGTLPWPQLKKEMGYFARVTKRVSSPQSTGTRKVNAVLMGRKTWDSIPPKFRPLKDRLNIVITRKADEFEKTLDKKSDVEGPMVASGIVDALAQLEGKAEEVDRVYVIGGASVYQTALELPQTRYVLLTKIRKEFECDTFFSVDLEESAVWRRAGREELQEFTGEEVKEKVIEEHGVEFEFCLYERV	MHKPTPLKRLSMILARDLNGAIGYEGSLAIKSDNDFAWYKKITKPFKHAVCGRVTYEEDLPDIVKKRHRFIIITRNPDKYASTPEAQYMTLSDALKELQVWDVPGHDIICLGGAEIYKALLPYVSTVYLTTFFSVADEADTYFNDFTDKWESVGATWFNDCYCTRLERVCQSTNNII	130.51	gnl|BL_ORD_ID|3105|hsp_num:0	4066		
scaffold_30_39 # 65177 # 65347 # 1 # ID=30_39;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.456	scaffold_30_39 	65177	65347	+	Strict	500	20.7866	sul3	100.0	3000413	protein homolog model	n/a	n/a	sulfonamide antibiotic	antibiotic target replacement	sulfonamide resistant sul	ATGGAGAGGAGAAGGAAGCGAGGTAGTGAAGTAGATCACTTGTACATGGGCACCGTATTATTGCATATGAGTACTGAAGACTACACTCTCCATATCTATGCTTTCCAAGGCTTTCCGTATCCCTTTGGCTTCCAGCACTCCAACCACGAGCTCAACGCACTCGTAAAATAA	MERRRKRGSEVDHLYMGTVLLHMSTEDYTLHIYAFQGFPYPFGFQHSNHELNALVK	MSKIFGIVNITTDSFSDGGLYLDTDKAIEHALHLVEDGADVIDLGAASSNPDTTEVGVVEEIKRLKPVIKALKEKGISISVDTFKPEVQSFCIEQKVDFINDIQGFPYPEIYSGLAKSDCKLVLMHSVQRIGAATKVETNPEEVFTSMMEFFKERIAALVEAGVKRERIILDPGMGFFLGSNPETSILVLKRFPEIQEAFNLQVMIAVSRKSFLGKITGTDVKSRLAPTLAAEMYAYKKGADYLRTHDVKSLSDALKISKALG	21.29	gnl|BL_ORD_ID|368|hsp_num:0	396	True	loose hit with at least 95 percent identity pushed strict
scaffold_40_32 # 85307 # 85582 # 1 # ID=40_32;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.514	scaffold_40_32 	85307	85582	+	Strict	700	22.7126	CMY-157	100.0	3005198	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGGGTGATGTCGATGTGGTCGAAGGGGTGGATGAAGTCGGCGCGCGTGATTATTTGTTGGGACTCCTGGAGTGGGATTTTGGGCAGTGTGAATTGGGACAGGGAGTGGTGCGTGGGAGGGGGTTGTTTGCGGTGGATGAGGGCGCTGGTAAGGATTATGGCTGCAGCCTGTGGAACACGTTACCATTTCGTACATTTGTTATAATCACGGGACGAGATGGTAAACCAGTACACGTACGTAAAATTTCTGCTGCTCCTCAACGTCGTCATCTATAG	MGDVDVVEGVDEVGARDYLLGLLEWDFGQCELGQGVVRGRGLFAVDEGAGKDYGCSLWNTLPFRTFVIITGRDGKPVHVRKISAAPQRRHL	MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNRPITQNTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTRYWPELTGKQWQNISLLHLATYTAGGLPLQIPDEVTDKTALLRFYQNWQPQWAPGAKRLYANSSIGLFGALAVKPSGMSYEGAMIRRVLQPLKLTHTWITVPQNEQRDYAWGYRDGKPVHVSPGQLDAEAYGVKSSIMDMARWVQVNMDASHVQEKTLQQGIGLAQSRYWRIGEMYQGLGWEMLNWPVKADTIINGSDSKIALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFIPEKNLGIVMLANKSYPNPARVDAAWRILEKLQ	23.88	gnl|BL_ORD_ID|2958|hsp_num:0	3917	True	loose hit with at least 95 percent identity pushed strict
scaffold_40_46 # 98456 # 98584 # -1 # ID=40_46;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=11-12bp;gc_cont=0.434	scaffold_40_46 	98456	98584	-	Strict	850	22.7126	OpmH	100.0	3003682	protein homolog model	n/a	n/a	triclosan	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATAATTGATCGTTGGTTCCAATGGATTGGTGTCTTGGCAGTATTGAGACGCAGACTGCCGGACGAAAGTGTACTCGTAGATGTCCTGTGGGTTAGTGATGAATCTGAGAATGGTAAAGAGACTTGA	MIIDRWFQWIGVLAVLRRRLPDESVLVDVLWVSDESENGKET	MLRRLSLAAAVAAATGVAWAAQPTPLPTKTDLISVYKEAVDNNADLAAAQADYLARKEVVPQARAGLLPQLGAGARVGDTRIAFDERPATVKRNSQVVQATLSQPLFRADRWFQWQAAKETSDQARLEFSATQQDLILRSAETYFTVLRAQDNLATSKAEEAAFKRQLDQANERFDVGLSDKTDVLEAQASYDTARANRLIAEQRVDDAFQALVTLTNRDYSAIEGMRHTLPVVPPAPNDAKAWVDTAVQQNLRLLASNYAVNAAEETLRQRKAGHLPTLDAVAQYQKGDNDALGFANSAANPLVHYGKYVDERSIGLELNIPIYSGGLTSSQVRESYQRLNQSEQSREGQRRQVVQDTRNLHRAVNTDVEQVQARRQAIISNQSSLEATEIGYQVGTRNIVDVLNAQRQLYAAVRDYNNSRYDYILDTLRLKQAAGTLSPADLEALSAYLKQDYDPDKDFLPPDLAKAAAEQLQSKPRQQY	8.71	gnl|BL_ORD_ID|2050|hsp_num:0	2195	True	loose hit with at least 95 percent identity pushed strict
scaffold_2_1469 # 1521709 # 1522020 # 1 # ID=2_1469;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.574	scaffold_2_1469 	1521709	1522020	+	Strict	500	22.3274	MexT	100.0	3000814	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCAGCAGCGACCGCTTGCGTACCTGGGCACGATTTGTGTAGAAGGACGGTTCTTTGTCCCACAATTCAATGGCCTTGGTGTAGAAATCCAGCGCGGCAGGCCAGTCCTGGTTCTTGAAAGCGTCGTTGCCCTTGTTTTTGAGCGCCGTGGCTTCTTCCTGTGGATTTCCCATGATGCGTGTGGAAGTGCGGGACACGGGCGTGGAAATGCGGTGCACAACGTGGACGGTTCGGGAAAGGACAACGGGTCGCTGCGTGTGTGGCAGGCAGTCGCGATGGAGCGCAGTTTCCCTAATTGCGTGCGCTTGTAA	VQQRPLAYLGTICVEGRFFVPQFNGLGVEIQRGRPVLVLESVVALVFERRGFFLWISHDACGSAGHGRGNAVHNVDGSGKDNGSLRVWQAVAMERSFPNCVRL	MPVSDPMPLRHLARPRPVSHARLDGEPPRLQPLAPGNEERHEPKRPAPRRSEPADRVRDPDARTQRDPRRRETVPRPAGQPAISAALSRLRTLFDDPLFVRTGRSMEPTARAQEIFAHLSPALDSISTAMSRASEFDPATSTAVFRIGLSDDVEFGLLPPLLRRLRAEAPGFVLVVRRANYLLMPNLLASGEISVGVSYTDELPANAKRKTVRRSKPKILRADSAPGQLTLDDYCARPHALVSFAGDLSGFVDEELEKFGRKRKVVLAVPQFNGLGTLLAGTDIIATVPDYAAQALIAAGGLRAEDPPFETRAFELSMAWRGAQDNDPAERWLRSRISMFIGDPDSL	29.68	gnl|BL_ORD_ID|1524|hsp_num:0	1608	True	loose hit with at least 95 percent identity pushed strict
scaffold_3_283 # 306289 # 306534 # 1 # ID=3_283;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.504	scaffold_3_283 	306289	306534	+	Strict	660	22.3274	MexS	100.0	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACTCTCGATCCATATGCCGATCCAGATGCTGATTCAGATCTCGCCGAAGATGAGATACCAGTCAGCATCCTCAATCCCATACCGCGGAAGCAGAACATGCCACCGCTGCCCGATCTTCGATTCGAACAGAGCTACCTCAAGAGCATAGAGTCGGCAAAATCTTGGAAGGACGTATTATGGATTACACTGAAGGACCAGGTACATGCAGAGGATTCCATGTGGCCAACCCATTGGCTAACCTGA	VTLDPYADPDADSDLAEDEIPVSILNPIPRKQNMPPLPDLRFEQSYLKSIESAKSWKDVLWITLKDQVHAEDSMWPTHWLT	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	23.89	gnl|BL_ORD_ID|1067|hsp_num:0	1041	True	loose hit with at least 95 percent identity pushed strict
